Payfazz has supplied a capital injection for the online payment services provider as the companies look to restructure themselves under a new umbrella.
Month: March 2021
Seebo sees its way through $24m round
The Phoenix has helped the Autodesk-backed manufacturing analytics technology provider raise $24m in an extended series B round.
DZS closes Rift acquisition deal
Intel Capital has exited the cloud network orchestration and automation software provider, which has been bought by DZS.
Corporate venturing deal net: 1-5 March 2021
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Houmo.ai handles Lenovo funding
Lenovo Capital participated in the first round to be disclosed by the artificial intelligence technology developer, which raised an undisclosed amount.
Nextmarkets nabs $30m
The Axel Springer-backed share trading platform developer secured $30m that will fund platform development and customer acquisition.
TytoCare hikes series D up to $100m
The medical examination software provider doubled the size of a round that includes Qualcomm Ventures along with its valuation.
Cashify calls in $15m
The Aihuishou-backed second-hand electronics platform operator has raked in new financing from an Olympus Capital subsidiary.
Netease helps Theorycraft assemble launch funding
Netease has led a $37.5m round disclosed by multiplayer game developer Theorycraft Games as it emerged from stealth.
Hopin hops to $400m series C
Salesforce Ventures took part in a round that near tripled the valuation of the virtual events platform developer to $5.65bn in just four months.
Crypto.com creates $200m corporate venturing fund
The cryptocurrency services and product provider will make strategic investments at seed or series A stage through the newly formed Crypto.com Capital.
SiCepat expedites with $170m series B close
Telkom Indonesia’s MDI Ventures unit has helped the e-commerce shipping platform complete its latest round, following an earlier tranche in December.
Century Therapeutics sells Bayer on $160m round
Returning investor Leaps by Bayer was among the participants in the cell-based immunotherapy developer’s series C round having previously led a $250m round in 2019.
Caribou Biosciences clinches $115m
Heritage Medical Systems and AbbVie Ventures took part in genome editing technology developer Caribou Biosciences’ first funding round in five years.